Salvage vs. Primary Total Laryngectomy in Patients with Locally Advanced Laryngeal or Hypopharyngeal Carcinoma: Oncologic Outcomes and Their Predictive Factors.
hypopharyngeal carcinoma
laryngeal carcinoma
larynx preservation
salvage surgery
total laryngectomy
Journal
Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588
Informations de publication
Date de publication:
07 Feb 2023
07 Feb 2023
Historique:
received:
30
12
2022
revised:
20
01
2023
accepted:
04
02
2023
entrez:
25
2
2023
pubmed:
26
2
2023
medline:
26
2
2023
Statut:
epublish
Résumé
The aims of this study were to compare the survival outcomes of salvage vs. primary total laryngectomy (TL) in patients with locally advanced laryngeal or hypopharyngeal carcinoma and to determine their predictive factors. Overall (OS), cause-specific (CSS) and recurrence-free survival (RFS) of primary vs. salvage TL were compared in univariate and multivariate analysis taking into account other potential predictive factors (tumor site, tumor stage, comorbidity level etc.). A total of 234 patients were included in this study. Five-year OS was 53% and 25% for the primary and salvage TL groups, respectively. Multivariate analysis confirmed the independent negative impact of salvage TL on OS ( Salvage TL is associated with significantly worse survival rates than primary TL highlighting the need for careful selection of patients who are candidates for larynx preservation. The predictive factors of survival outcomes identified here should be considered in the therapeutic decision-making, especially in the setting of salvage TL, given the poor prognosis of these patients.
Sections du résumé
BACKGROUND
BACKGROUND
The aims of this study were to compare the survival outcomes of salvage vs. primary total laryngectomy (TL) in patients with locally advanced laryngeal or hypopharyngeal carcinoma and to determine their predictive factors.
METHODS
METHODS
Overall (OS), cause-specific (CSS) and recurrence-free survival (RFS) of primary vs. salvage TL were compared in univariate and multivariate analysis taking into account other potential predictive factors (tumor site, tumor stage, comorbidity level etc.).
RESULTS
RESULTS
A total of 234 patients were included in this study. Five-year OS was 53% and 25% for the primary and salvage TL groups, respectively. Multivariate analysis confirmed the independent negative impact of salvage TL on OS (
CONCLUSIONS
CONCLUSIONS
Salvage TL is associated with significantly worse survival rates than primary TL highlighting the need for careful selection of patients who are candidates for larynx preservation. The predictive factors of survival outcomes identified here should be considered in the therapeutic decision-making, especially in the setting of salvage TL, given the poor prognosis of these patients.
Identifiants
pubmed: 36835841
pii: jcm12041305
doi: 10.3390/jcm12041305
pmc: PMC9958790
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Cancers (Basel). 2020 Mar 03;12(3):
pubmed: 32138168
Eur J Surg Oncol. 2021 Nov;47(11):2711-2721
pubmed: 34059377
Laryngoscope. 2000 Mar;110(3 Pt 2 Suppl 93):1-18
pubmed: 10714711
Ann Oncol. 2012 Oct;23(10):2708-2714
pubmed: 22492697
Oral Oncol. 2022 Oct;133:106026
pubmed: 35914443
Arch Otolaryngol Head Neck Surg. 2000 Dec;126(12):1473-7
pubmed: 11115285
N Engl J Med. 2003 Nov 27;349(22):2091-8
pubmed: 14645636
Laryngoscope. 2009 Nov;119(11):2135-40
pubmed: 19507214
Eur Arch Otorhinolaryngol. 2011 Feb;268(2):295-301
pubmed: 20721572
Otolaryngol Head Neck Surg. 2014 Sep;151(3):454-61
pubmed: 24894422
Laryngoscope. 2021 Feb;131(2):E569-E575
pubmed: 32770763
Int J Radiat Oncol Biol Phys. 2015 Jul 1;92(3):594-601
pubmed: 26068492
Head Neck. 2010 Feb;32(2):139-47
pubmed: 19536855
Head Neck. 2016 Apr;38 Suppl 1:E1962-8
pubmed: 26879395
Cancers (Basel). 2020 Mar 20;12(3):
pubmed: 32244899
Laryngoscope. 2006 Sep;116(9 Pt 2 Suppl 111):1-13
pubmed: 16946667
Front Oncol. 2019 May 31;9:419
pubmed: 31214491
Surg Oncol. 2018 Dec;27(4):767-772
pubmed: 30449505
Head Neck. 2017 Dec;39(12):2512-2518
pubmed: 28963806
Cancers (Basel). 2021 Mar 23;13(6):
pubmed: 33806944
J Natl Cancer Inst. 2015 Dec 16;108(4):
pubmed: 26681800
JAMA Otolaryngol Head Neck Surg. 2023 Jan 1;149(1):24-33
pubmed: 36394866
Arch Otolaryngol Head Neck Surg. 2003 Jan;129(1):44-9
pubmed: 12525193
Head Neck. 2012 Feb;34(2):270-81
pubmed: 22228621
Head Neck. 2017 Mar;39(3):555-563
pubmed: 27902867
Laryngoscope. 2020 Sep;130(9):2179-2185
pubmed: 31654445
Laryngoscope. 2013 Apr;123(4):910-5
pubmed: 23483475
N Engl J Med. 1991 Jun 13;324(24):1685-90
pubmed: 2034244
Oral Oncol. 2011 Apr;47(4):296-301
pubmed: 21356604
Laryngoscope. 2001 Jun;111(6):1079-87
pubmed: 11404625
CA Cancer J Clin. 2017 Jan;67(1):31-50
pubmed: 27898173